These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19441125)

  • 21. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M; Goyal A; Jaryal A; Sharma A; Gupta PK; Ramachandran R; Kumar V; Kohli HS; Sakhuja V; Jha V; Gupta KL
    Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital malformations with low-dose mycophenolate mofetil after kidney transplantation.
    Koshy AN; Strong D; Earles G; Fassett RG
    Nephrology (Carlton); 2010 Feb; 15(1):133-5. PubMed ID: 20377782
    [No Abstract]   [Full Text] [Related]  

  • 24. Surveillance for the use of mycophenolate mofetil for adult patients with lupus nephritis in Japan.
    Yasuda S; Atsumi T; Shimamura S; Ono K; Hiromura K; Sada K; Mori M; Takei S; Kawaguchi Y; Tamura N; Takasaki Y
    Mod Rheumatol; 2015; 25(6):854-7. PubMed ID: 25800636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].
    Zierhut M; Stübiger N; Aboalchamat W; Landenberger H; Bialasiewicz AA; Engelmann K
    Ophthalmologe; 2001 Jul; 98(7):647-51. PubMed ID: 11490743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teratogen update: methotrexate.
    Hyoun SC; Običan SG; Scialli AR
    Birth Defects Res A Clin Mol Teratol; 2012 Apr; 94(4):187-207. PubMed ID: 22434686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycophenolate mofetil or cyclophosphamide in indian patients with lupus nephritis: Which is better? A single-center experience.
    Mendonca S; Gupta D; Ali S; Gupta P
    Saudi J Kidney Dis Transpl; 2017; 28(5):1069-1077. PubMed ID: 28937065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone.
    Pérgola PE; Kancharla A; Riley DJ
    Transplantation; 2001 Apr; 71(7):994-7. PubMed ID: 11349738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary lymphoma of CNS, mycophenolate mofetil and lupus.
    Finelli PF; Naik K; DiGiuseppe JA; Prasad A
    Lupus; 2006; 15(12):886-8. PubMed ID: 17211996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats.
    Jia Y; Wang R; Li L; Zhang Y; Li J; Wang J; Wang X; Qi G; Rong R; Xu M; Zhu T
    BMC Pharmacol Toxicol; 2018 Jul; 19(1):39. PubMed ID: 29973291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal quality of life improvement of renal transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium drugs or agents: mycophenolate mofetil and enteric-coated mycophenolate sodium.
    Ortega F; Sánchez-Fructuoso A; Cruzado JM; Gómez-Alamillo JC; Alarcón A; Pallardó L; Morales JM; Oliver J; Guinea G;
    Transplantation; 2011 Aug; 92(4):426-32. PubMed ID: 21760569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined chemotherapy and teratogenicity.
    Paskulin GA; Gazzola Zen PR; de Camargo Pinto LL; Rosa R; Graziadio C
    Birth Defects Res A Clin Mol Teratol; 2005 Sep; 73(9):634-7. PubMed ID: 16104005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycophenolate mofetil exposure on embryonic and fetal ear development in rats during pregnancy.
    Chen Q; Zhang Y; Luo Y; Li G
    Birth Defects Res; 2023 Sep; 115(15):1411-1423. PubMed ID: 37602693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis.
    Gadakchi L; Hajialilo M; Nakhjavani MR; Abedi Azar S; Kolahi S; Gojazadeh M; Ebrahimi AA; Malek Mahdavi A; Noshad H; Khabbazi A
    Iran J Kidney Dis; 2018 Oct; 12(5):288-292. PubMed ID: 30367020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and efficacy of MMF in lupus nephritis: a pilot study.
    Kingdon EJ; McLean AG; Psimenou E; Davenport A; Powis SH; Sweny P; Burns A
    Lupus; 2001; 10(9):606-11. PubMed ID: 11678448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial.
    Sedhain A; Hada R; Agrawal RK; Bhattarai GR; Baral A
    BMC Nephrol; 2018 Jul; 19(1):175. PubMed ID: 29996800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate Mofetil and Pulmonary Fibrosis After Kidney Transplantation: A Case Report.
    Takahashi K; Go P; Stone CH; Safwan M; Putchakayala KG; Kane WJ; Malinzak LE; Kim DY; Denny JE
    Am J Case Rep; 2017 Apr; 18():399-404. PubMed ID: 28408734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation.
    Cassina M; Cagnoli GA; Zuccarello D; Di Gianantonio E; Clementi M
    Eur J Med Genet; 2017 Jan; 60(1):22-31. PubMed ID: 27639441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K; Ross S; Benz K; Amann K; Dötsch J
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limits to intensified mycophenolate mofetil dosing in kidney transplantation.
    Kiberd BA; Lawen J; Daley C
    Ther Drug Monit; 2012 Dec; 34(6):736-8. PubMed ID: 23007746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.